Stay updated with breaking news from Nasdaq Tech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
William Blair began coverage on shares of Bio-Techne (NASDAQ:TECH – Free Report) in a research report released on Monday morning, MarketBeat reports. The firm issued an outperform rating on the biotechnology company’s stock. William Blair also issued estimates for Bio-Techne’s Q1 2024 earnings at $0.40 EPS, Q2 2024 earnings at $0.40 EPS, Q3 2024 earnings […]
Itau Unibanco Holding S.A. boosted its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 322.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,621 shares of the biotechnology company’s stock after acquiring an additional 5,052 shares during the period. […]
Bio-Techne Co. (NASDAQ:TECH – Get Free Report) shares traded down 2% during trading on Monday . The stock traded as low as $77.54 and last traded at $78.57. 184,823 shares traded hands during trading, a decline of 81% from the average session volume of 979,527 shares. The stock had previously closed at $80.16. Wall Street […]
Rhenman & Partners Asset Management AB reduced its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 38.9% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 55,000 shares of the biotechnology company’s stock after selling 35,000 shares during the […]
Bio-Techne (NASDAQ:TECH – Get Free Report) and AVROBIO (NASDAQ:AVRO – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, dividends, profitability and institutional ownership. Profitability This table compares Bio-Techne and AVROBIO’s net margins, return […]